K. McAulay

发表

Studies on Immune Regulation of Epstein-Barr Virus

K. McAulay, 2008 .

Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion.

P. Hayes, W. Bickmore, K. Samuel, 2003, Gastroenterology.

Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children

S. Rowland-Jones, H. Whittle, A. Rickinson, 2015, PLoS pathogens.

Infectious mononucleosis in university students in the United kingdom: evaluation of the clinical features and consequences of the disease.

A. Swerdlow, D. Crawford, C. Higgins, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evidence of shared Epstein‐Barr viral isolates between sexual partners, and low level EBV in genital secretions

A. Swerdlow, D. Clutterbuck, D. Crawford, 2006, Journal of medical virology.

Evaluation of the antibody response to the EBV proteome in EBV‐associated classical Hodgkin lymphoma

H. Adami, R. Pfeiffer, E. Chang, 2020, International journal of cancer.

Human leukocyte antigens and genetic susceptibility to lymphoma.

R. Jarrett, K. McAulay, Karen A. McAulay, 2015, Tissue antigens.

Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease

D. Crawford, T. Haque, K. McAulay, 2009, British Journal of Cancer.

Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease.

D. Crawford, C. Higgins, K. McAulay, 2005, Blood.

The immune response to primary EBV infection: a role for natural killer cells

A. Swerdlow, D. Crawford, C. Higgins, 2005, British journal of haematology.

Epstein-Barr Virus Can Establish Infection in the Absence of a Classical Memory B-Cell Population

R. Callard, D. Kumararatne, H. Chapel, 2005, Journal of Virology.

Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial

Karen McAulay, Gordon D Murray, G. Murray, 2000, The Lancet.

trial lymphoproliferative disease: results of a phase 2 multicenter clinical Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation

A. Swerdlow, M. Gandhi, M. Turner, 2013 .

Soluble CD30: A serum marker for Epstein–Barr virus‐associated lymphoproliferative diseases

D. Crawford, C. Atkinson, T. Haque, 2011, Journal of medical virology.

Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up.

D. Kelly, D. Crawford, T. Haque, 2010, Transplantation.

EBV+ diffuse large B-cell lymphoma arising within atrial myxoma. An example of a distinct primary cardiac EBV+ DLBCL of immunocompetent patients.

K. McAulay, R. Jaksa, A. Švec, 2012, Pathology, research and practice.

Analysis of immune activation and clinical events in acute infectious mononucleosis.

A. Swerdlow, D. Crawford, C. Higgins, 2004, The Journal of infectious diseases.

A study of risk factors for acquisition of Epstein-Barr virus and its subtypes.

A. Swerdlow, D. Crawford, C. Higgins, 2007, The Journal of infectious diseases.

A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.

A. Swerdlow, D. Crawford, C. Higgins, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

A. Swerdlow, M. Gandhi, M. Turner, 2007, Blood.

Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease1

C. Bellamy, D. Crawford, T. Haque, 2009, The Journal of Immunology.

Sexual history and Epstein-Barr virus infection.

A. Swerdlow, D. Crawford, C. Higgins, 2002, The Journal of infectious diseases.

Cytolytic mechanisms and T‐cell receptor Vβ usage by ex vivo generated Epstein–Barr virus‐specific cytotoxic T lymphocytes

M. Turner, D. Crawford, T. Haque, 2009, Immunology.

Response : PTLD risk and IFNG polymorphisms

D. Crawford, C. Higgins, K. McAulay, 2005 .

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

D. Crawford, R. Jarrett, A. Lake, 2007, The Journal of clinical investigation.

Regulatory T cell activity in primary and persistent Epstein–Barr virus infection

I. Anthony, D. Crawford, K. McAulay, 2009, Journal of medical virology.

Modeling HLA associations with EBV‐positive and ‐negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis

G. M. Taylor, A. Little, S. Marsh, 2015, International journal of cancer.

The Plasmin-Sensitive Protein Pls in Methicillin-Resistant Staphylococcus aureus (MRSA) Is a Glycoprotein

S. Foster, J. Eikmeier, G. Pohlentz, 2017, PLoS pathogens.

Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group.

D. Stott, L. Wallace, W. Carman, 1999, The Journal of infection.

Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis.

G. Ebers, G. Giovannoni, S. Ramagopalan, 2011, Archives of neurology.